Meeder Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Meeder Asset Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11	Closed	-$1K	–	2745
2021 Q1	$1K	Buy	+11	New	+$859	﹤0.01%	2303
2020 Q1	–	Sell	-8	Closed	-$1K	–	2639
2019 Q4	$1K	Sell	8 -14	-64%	-$1.02K	﹤0.01%	2203
2019 Q3	$2K	Sell	22 -49	-69%	-$4.15K	﹤0.01%	2017
2019 Q2	$6K	Sell	71 -98	-58%	-$6.89K	﹤0.01%	1640
2019 Q1	$11K	Hold	169	–	–	﹤0.01%	1225
2018 Q4	$13K	Buy	+169	New	+$14K	﹤0.01%	1180
2018 Q3	–	Sell	-1,658	Closed	-$163K	–	1751
2018 Q2	$163K	Buy	1,658 +1,636	+7,436%	+$183K	0.01%	537
2018 Q1	$2K	Buy	+22	New	+$2.47K	﹤0.01%	1421
2017 Q2	–	Sell	-17	Closed	-$1K	–	1976
2017 Q1	$1K	Buy	+17	New	+$1.35K	﹤0.01%	1592

Meeder Asset Management's CMD Position: Q2 2021 in Review

Meeder Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 11 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in CMD in Q1 2017 and held it in 9 quarters. The position peaked at $163K in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Meeder Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Meeder Asset Management sold 11 Cantel Medical Corporation shares in Q2 2021, an estimated $1K.
Meeder Asset Management first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 9 quarters.
Meeder Asset Management's Cantel Medical Corporation position peaked at $163K in Q2 2018.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Meeder Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.